Copyright Reports & Markets. All rights reserved.

Global Hazardous Drug Compounding Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Structural Form
    • 1.3.1 Overview: Global Hazardous Drug Compounding Systems Consumption Value by Structural Form: 2021 Versus 2025 Versus 2032
    • 1.3.2 Closed Compounding Module
    • 1.3.3 Semi-Closed Compounding Module
    • 1.3.4 Open Compounding Module
  • 1.4 Market Analysis by Operational Scale
    • 1.4.1 Overview: Global Hazardous Drug Compounding Systems Consumption Value by Operational Scale: 2021 Versus 2025 Versus 2032
    • 1.4.2 Single-Patient Compounding System
    • 1.4.3 Batch Compounding System
    • 1.4.4 Centralized Compounding System
  • 1.5 Market Analysis by Functional Attribute
    • 1.5.1 Overview: Global Hazardous Drug Compounding Systems Consumption Value by Functional Attribute: 2021 Versus 2025 Versus 2032
    • 1.5.2 Contamination Control System
    • 1.5.3 Dosage Precision System
    • 1.5.4 Environmental Monitoring System
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Hazardous Drug Compounding Systems Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital Pharmacies
    • 1.6.3 Outpatient/Community Pharmacies
    • 1.6.4 Research and Development Laboratories
    • 1.6.5 Others
  • 1.7 Global Hazardous Drug Compounding Systems Market Size & Forecast
    • 1.7.1 Global Hazardous Drug Compounding Systems Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Hazardous Drug Compounding Systems Sales Quantity (2021-2032)
    • 1.7.3 Global Hazardous Drug Compounding Systems Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BD Medical
    • 2.1.1 BD Medical Details
    • 2.1.2 BD Medical Major Business
    • 2.1.3 BD Medical Hazardous Drug Compounding Systems Product and Services
    • 2.1.4 BD Medical Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BD Medical Recent Developments/Updates
  • 2.2 Equashield
    • 2.2.1 Equashield Details
    • 2.2.2 Equashield Major Business
    • 2.2.3 Equashield Hazardous Drug Compounding Systems Product and Services
    • 2.2.4 Equashield Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Equashield Recent Developments/Updates
  • 2.3 ICU Medical
    • 2.3.1 ICU Medical Details
    • 2.3.2 ICU Medical Major Business
    • 2.3.3 ICU Medical Hazardous Drug Compounding Systems Product and Services
    • 2.3.4 ICU Medical Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ICU Medical Recent Developments/Updates
  • 2.4 B. Braun
    • 2.4.1 B. Braun Details
    • 2.4.2 B. Braun Major Business
    • 2.4.3 B. Braun Hazardous Drug Compounding Systems Product and Services
    • 2.4.4 B. Braun Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 B. Braun Recent Developments/Updates
  • 2.5 Baxter
    • 2.5.1 Baxter Details
    • 2.5.2 Baxter Major Business
    • 2.5.3 Baxter Hazardous Drug Compounding Systems Product and Services
    • 2.5.4 Baxter Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Baxter Recent Developments/Updates
  • 2.6 Comecer
    • 2.6.1 Comecer Details
    • 2.6.2 Comecer Major Business
    • 2.6.3 Comecer Hazardous Drug Compounding Systems Product and Services
    • 2.6.4 Comecer Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Comecer Recent Developments/Updates
  • 2.7 Grifols
    • 2.7.1 Grifols Details
    • 2.7.2 Grifols Major Business
    • 2.7.3 Grifols Hazardous Drug Compounding Systems Product and Services
    • 2.7.4 Grifols Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Grifols Recent Developments/Updates
  • 2.8 ARxIUM
    • 2.8.1 ARxIUM Details
    • 2.8.2 ARxIUM Major Business
    • 2.8.3 ARxIUM Hazardous Drug Compounding Systems Product and Services
    • 2.8.4 ARxIUM Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 ARxIUM Recent Developments/Updates
  • 2.9 NewIcon
    • 2.9.1 NewIcon Details
    • 2.9.2 NewIcon Major Business
    • 2.9.3 NewIcon Hazardous Drug Compounding Systems Product and Services
    • 2.9.4 NewIcon Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 NewIcon Recent Developments/Updates
  • 2.10 Kapsam
    • 2.10.1 Kapsam Details
    • 2.10.2 Kapsam Major Business
    • 2.10.3 Kapsam Hazardous Drug Compounding Systems Product and Services
    • 2.10.4 Kapsam Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Kapsam Recent Developments/Updates
  • 2.11 Omnicell
    • 2.11.1 Omnicell Details
    • 2.11.2 Omnicell Major Business
    • 2.11.3 Omnicell Hazardous Drug Compounding Systems Product and Services
    • 2.11.4 Omnicell Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Omnicell Recent Developments/Updates
  • 2.12 QuartetRX
    • 2.12.1 QuartetRX Details
    • 2.12.2 QuartetRX Major Business
    • 2.12.3 QuartetRX Hazardous Drug Compounding Systems Product and Services
    • 2.12.4 QuartetRX Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 QuartetRX Recent Developments/Updates
  • 2.13 Simplivia Healthcare
    • 2.13.1 Simplivia Healthcare Details
    • 2.13.2 Simplivia Healthcare Major Business
    • 2.13.3 Simplivia Healthcare Hazardous Drug Compounding Systems Product and Services
    • 2.13.4 Simplivia Healthcare Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Simplivia Healthcare Recent Developments/Updates
  • 2.14 Corvida Medical
    • 2.14.1 Corvida Medical Details
    • 2.14.2 Corvida Medical Major Business
    • 2.14.3 Corvida Medical Hazardous Drug Compounding Systems Product and Services
    • 2.14.4 Corvida Medical Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Corvida Medical Recent Developments/Updates
  • 2.15 Loccioni
    • 2.15.1 Loccioni Details
    • 2.15.2 Loccioni Major Business
    • 2.15.3 Loccioni Hazardous Drug Compounding Systems Product and Services
    • 2.15.4 Loccioni Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Loccioni Recent Developments/Updates
  • 2.16 EPIC Medical
    • 2.16.1 EPIC Medical Details
    • 2.16.2 EPIC Medical Major Business
    • 2.16.3 EPIC Medical Hazardous Drug Compounding Systems Product and Services
    • 2.16.4 EPIC Medical Hazardous Drug Compounding Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 EPIC Medical Recent Developments/Updates

3 Competitive Environment: Hazardous Drug Compounding Systems by Manufacturer

  • 3.1 Global Hazardous Drug Compounding Systems Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hazardous Drug Compounding Systems Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hazardous Drug Compounding Systems Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hazardous Drug Compounding Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hazardous Drug Compounding Systems Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hazardous Drug Compounding Systems Manufacturer Market Share in 2025
  • 3.5 Hazardous Drug Compounding Systems Market: Overall Company Footprint Analysis
    • 3.5.1 Hazardous Drug Compounding Systems Market: Region Footprint
    • 3.5.2 Hazardous Drug Compounding Systems Market: Company Product Type Footprint
    • 3.5.3 Hazardous Drug Compounding Systems Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hazardous Drug Compounding Systems Market Size by Region
    • 4.1.1 Global Hazardous Drug Compounding Systems Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hazardous Drug Compounding Systems Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hazardous Drug Compounding Systems Average Price by Region (2021-2032)
  • 4.2 North America Hazardous Drug Compounding Systems Consumption Value (2021-2032)
  • 4.3 Europe Hazardous Drug Compounding Systems Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hazardous Drug Compounding Systems Consumption Value (2021-2032)
  • 4.5 South America Hazardous Drug Compounding Systems Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hazardous Drug Compounding Systems Consumption Value (2021-2032)

5 Market Segment by Structural Form

  • 5.1 Global Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 5.2 Global Hazardous Drug Compounding Systems Consumption Value by Structural Form (2021-2032)
  • 5.3 Global Hazardous Drug Compounding Systems Average Price by Structural Form (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 6.2 Global Hazardous Drug Compounding Systems Consumption Value by Application (2021-2032)
  • 6.3 Global Hazardous Drug Compounding Systems Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 7.2 North America Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 7.3 North America Hazardous Drug Compounding Systems Market Size by Country
    • 7.3.1 North America Hazardous Drug Compounding Systems Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hazardous Drug Compounding Systems Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 8.2 Europe Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hazardous Drug Compounding Systems Market Size by Country
    • 8.3.1 Europe Hazardous Drug Compounding Systems Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hazardous Drug Compounding Systems Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 9.2 Asia-Pacific Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hazardous Drug Compounding Systems Market Size by Region
    • 9.3.1 Asia-Pacific Hazardous Drug Compounding Systems Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hazardous Drug Compounding Systems Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 10.2 South America Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 10.3 South America Hazardous Drug Compounding Systems Market Size by Country
    • 10.3.1 South America Hazardous Drug Compounding Systems Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hazardous Drug Compounding Systems Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hazardous Drug Compounding Systems Sales Quantity by Structural Form (2021-2032)
  • 11.2 Middle East & Africa Hazardous Drug Compounding Systems Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hazardous Drug Compounding Systems Market Size by Country
    • 11.3.1 Middle East & Africa Hazardous Drug Compounding Systems Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hazardous Drug Compounding Systems Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hazardous Drug Compounding Systems Market Drivers
  • 12.2 Hazardous Drug Compounding Systems Market Restraints
  • 12.3 Hazardous Drug Compounding Systems Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hazardous Drug Compounding Systems and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hazardous Drug Compounding Systems
  • 13.3 Hazardous Drug Compounding Systems Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hazardous Drug Compounding Systems Typical Distributors
  • 14.3 Hazardous Drug Compounding Systems Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hazardous Drug Compounding Systems market size was valued at US$ 4244 million in 2025 and is forecast to a readjusted size of US$ 6890 million by 2032 with a CAGR of 7.1% during review period.
    In 2025, global Hazardous Drug Compounding Systems production reached approximately 21.4 K units, with an average global market price of around 192,500 USD/unit.
    A Hazardous Drug Compounding System is an integrated closed pharmaceutical processing system that performs sterile, accurate, and contamination-free preparation, dispensing, and transfer of hazardous cytotoxic and antineoplastic drugs, protecting medical staff from occupational exposure, ensuring drug dosing precision, and complying with healthcare and pharmaceutical compounding safety regulations.
    Escalating global hazardous drug handling regulatory standards, growing oncology drug utilization, and rising focus on medical staff occupational health drive sustained demand for Hazardous Drug Compounding Systems; this creates significant business opportunities in intelligent closed system manufacturing, regulatory-compliant customization, equipment validation, and aftermarket services for tertiary hospitals, cancer centers, and centralized pharmaceutical compounding facilities.
    This report is a detailed and comprehensive analysis for global Hazardous Drug Compounding Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Structural Form and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hazardous Drug Compounding Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hazardous Drug Compounding Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hazardous Drug Compounding Systems market size and forecasts, by Structural Form and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hazardous Drug Compounding Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hazardous Drug Compounding Systems
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hazardous Drug Compounding Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD Medical, Equashield, ICU Medical, B. Braun, Baxter, Comecer, Grifols, ARxIUM, NewIcon, Kapsam, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hazardous Drug Compounding Systems market is split by Structural Form and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Structural Form, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Structural Form
    Closed Compounding Module
    Semi-Closed Compounding Module
    Open Compounding Module
    Market segment by Operational Scale
    Single-Patient Compounding System
    Batch Compounding System
    Centralized Compounding System
    Market segment by Functional Attribute
    Contamination Control System
    Dosage Precision System
    Environmental Monitoring System
    Market segment by Application
    Hospital Pharmacies
    Outpatient/Community Pharmacies
    Research and Development Laboratories
    Others
    Major players covered
    BD Medical
    Equashield
    ICU Medical
    B. Braun
    Baxter
    Comecer
    Grifols
    ARxIUM
    NewIcon
    Kapsam
    Omnicell
    QuartetRX
    Simplivia Healthcare
    Corvida Medical
    Loccioni
    EPIC Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hazardous Drug Compounding Systems product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hazardous Drug Compounding Systems, with price, sales quantity, revenue, and global market share of Hazardous Drug Compounding Systems from 2021 to 2026.
    Chapter 3, the Hazardous Drug Compounding Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hazardous Drug Compounding Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Structural Form and by Application, with sales market share and growth rate by Structural Form, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hazardous Drug Compounding Systems market forecast, by regions, by Structural Form, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hazardous Drug Compounding Systems.
    Chapter 14 and 15, to describe Hazardous Drug Compounding Systems sales channel, distributors, customers, research findings and conclusion.

    Buy now